NCT03372980
- Conditions
- Aortic Arch Syndromes, Aortic Diseases, Arteritis, +8 more
- Locations
-
- Beijing Anzhen Hospital Beijing, Beijing Municipality, China
Clinical trial condition
Vasculitis
Explore clinical trials studying Vasculitis. Study availability and eligibility vary by location and protocol.
469 public trials
135 recruiting studies
Vasculitis trial results
NCT05315141
- Conditions
- ANCA Associated Vasculitis, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, +21 more
- Locations
-
- Xiangya hospital Changsha, Hunan, China
NCT04300686
- Conditions
- Adalimumab, Aortic Arch Syndromes, Aortic Diseases, +10 more
- Locations
-
- Department of Rheumatology in Zhongshan hospital, Fudan University Shanghai, Shanghai Municipality, China
NCT04538937
- Conditions
- Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, Cardiovascular Diseases, +24 more
- Locations
-
- University Clinic for Internal Medicine II Innsbruck, Austria
NCT02964364
- Conditions
- Aortic Arch Syndromes, Aortic Diseases, Arteritis, +7 more
- Locations
-
- Fuwai Hospital Beijing, Beijing Municipality, China
Enrolling by Invitation
Phase 1b Long-term Extension Trial of RAY121 in Immunological Diseases (RAINBOW-LTE Trial)
NCT06723106
- Conditions
- Antiphospholipid Syndrome, Antiphospholipid Syndrome (APS), Autoimmune Diseases, +50 more
- Locations
-
- Royal Prince Alfred Hospital Camperdown, New South Wales, Australia
- Westmead Hospital Sydney, New South Wales, Australia
- Campbelltown Public Hospital Sydney, New South Wales, Australia
- The Alfred Hospital Melbourne, Victoria, Australia
Enrolling by Invitation
A Phase 1 Study of Prulacabtagene Leucel (Prula-cel, Formerly ADI-001) in Autoimmune Disease
NCT06375993
- Conditions
- ANCA-Associated Vasculitis (AAV), Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, +33 more
- Locations
-
- Adicet Clinical Trials Redwood City, California, United States
- Roswell Park Comprehensive Cancer Center Buffalo, New York, United States
Enrolling by Invitation
Beyond EOsinophils: proteoMICS to Identify Potential Biomarker of Organ Damage and Response to MEPOLIZUMAB in EGPA
NCT07343661
- Conditions
- Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Asthma, Autoimmune Diseases, +28 more
- Locations
-
- Policlinico Duilio Casula AOU Cagliari Cagliari, Italy
Enrolling by Invitation
Follow-up Study Using Gene Therapy for Critical Limb Ischemia (NL003-CLI-III-L)
NCT07023965
- Conditions
- Arterial Occlusive Disease, Arterial Occlusive Diseases, Arteriosclerosis, +29 more
- Locations
-
- Peking Union Medical College Hospital, Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
- Chifeng Municipal Hospital Chifeng, Neimenggu, China
- zhongshan Hospital Affiliated of Dalian University Dalian, Shenyang, China
- The First Affiliated Hospital, Zhejiang University School of Medicine Hangzhou, China
Enrolling by Invitation
Vaccination Against Herpes Zoster in Patients With Inflammatory Rheumatic Diseases
NCT06763783
- Conditions
- Arteritis, Arthritis, Arthritis, Juvenile, +45 more
- Locations
-
- Skåne University Hospital, section for rheumatology Lund, Sweden